Rational Design of Conformationally Constrained Cyclopentapeptide Antagonists for C-X-C Chemokine Receptor 4 (CXCR4)-Reference-Cited by-同舟云学术

Rational Design of Conformationally Constrained Cyclopentapeptide Antagonists for C-X-C Chemokine Receptor 4 (CXCR4)

Published:2012-10-22 Issue:22 Volume:55 Page:10287-10291
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Mungalpara Jignesh,Thiele Stefanie¹,Eriksen Øystein,Eksteen Johann²,Rosenkilde Mette M.¹,Våbenø Jon

Affiliation:

1. Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, The Panum Institute, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen, Denmark

2. Lytix Biopharma, Tromsø Science Park AS, P.O. Box 6447, NO-9294 Tromsø, Norway

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm300926y

Reference30 articles.

1. HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

2. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains

3. Molecular Pharmacology of CXCR4 Inhibition

4. The significance of cancer cell expression of the chemokine receptor CXCR4

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and therapeutic perspectives of CXCR4 antagonists for disease therapy;European Journal of Medicinal Chemistry;2024-09

2. Computational modeling and experimental validation of the EPI-X4/CXCR4 complex allows rational design of small peptide antagonists;Communications Biology;2021-09-22

3. A Rapid and Specific HPLC Method to Determine Chemical and Radiochemical Purity of [68>Ga]Ga-DOTA-Pentixafor (PET) Tracer: Development and Validation;Current Radiopharmaceuticals;2021-06-04

4. Biomolecular models of EPI-X4 binding to CXCR4 allow the rational optimization of peptides with therapeutic potential;2020-10-24

5. Disulfide Bond Replacement with 1,4‐ and 1,5‐Disubstituted [1,2,3]‐Triazole on C‐X‐C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big Differences;Chemistry – A European Journal;2020-07-20